ERBB2 and breast carcinoma: As shown in Figure 2; Supplementary Figure 2, OS (p = 0.015), DMFS (p = 0.004) and PPS (p = 0.023) were shorter in basal breast cancer patients with low NR1H3 expression, but not in luminal A, luminal B and HER2+ breast cancer patients (p > 0.05).